Suppr超能文献

肥胖对腿部慢性水肿/淋巴水肿的影响——一项国际多中心横断面研究(LIMPRINT)。

The impact of obesity on chronic oedema/lymphoedema of the leg - an international multicenter cross-sectional study (LIMPRINT).

机构信息

Department of Dermato-Venereology & Wound Healing Centre, Bispebjerg Hospital, Copenhagen University Hospital, Copenhagen, Denmark.

Steno Diabetes Center Copenhagen, Herlev, Denmark.

出版信息

Int J Obes (Lond). 2024 Sep;48(9):1238-1247. doi: 10.1038/s41366-024-01544-0. Epub 2024 Jul 3.

Abstract

BACKGROUND/OBJECTIVES: Obesity and chronic oedema/lymphoedema are two distinct but related conditions, rarely investigated together. The aim was to study the impact of increased weight on chronic oedema and related factors.

SUBJECTS/METHODS: A cross-sectional study, 38 centers, nine countries. Patients with clinically confirmed chronic oedema/lymphoedema of the leg were included. Weight category was estimated as: normal weight (BMI 20-30), class I-II obesity (BMI 30-40), or class III obesity (BMI > 40). Factors were tested for an association with increased weight, using a multivariable model.

RESULTS

A total of 7397 patients were included; 43% with normal weight, 36% class I-II obesity and 21% class III obesity. Increased weight was associated with more advanced stages of chronic oedema (ISL stage III; the most advanced form); affecting 14% in normal weight, 18% class I-II obesity and 39% class III obesity (p < 0.001). Ten factors were independently associated with increased weight: diabetes (OR 2.4), secondary lymphoedema (OR 2.7), cellulitis/erysipelas within 12 months (OR 1.2), bilateral lymphoedema (OR 3.6), compression therapy (OR 2.1), increased swelling duration (1-2 years OR 1.3, 2-5 years OR 2.5, 5-10 years OR 3.6, >10 years OR 3.5) decreased mobility (walking with aid OR 1.9, being chair bound OR 1.2) and age (reference<45 years; 45-64 years OR 1.5, 75-84 years OR 0.6, 85+ years OR 0.2). Increased weight was associated with a lower presentation of peripheral arterial disease (OR 0.7) and poorer chronic oedema control (OR 0.8). Patients with obesity had lower function, appearance and more severe symptoms (LYMQOL) and lower quality of life (EuroQol).

CONCLUSIONS

Obesity negatively impacts chronic oedema, leading to more advanced stages. Achieving good control of swelling with compression is more difficult in these patients. Increased awareness of chronic oedema/lymphoedema as a complication of obesity is important for early detection and for developing effective strategies to prevent and manage them.

摘要

背景/目的:肥胖症和慢性水肿/淋巴水肿是两种不同但相关的疾病,很少同时进行研究。本研究旨在探讨体重增加对慢性水肿和相关因素的影响。

对象/方法:这是一项横断面研究,共涉及 38 个中心,分布在 9 个国家。研究纳入了经临床确诊的下肢慢性水肿/淋巴水肿患者。体重类别估计为:正常体重(BMI 20-30)、I 级-II 级肥胖症(BMI 30-40)或 III 级肥胖症(BMI>40)。采用多变量模型,对与体重增加相关的因素进行了检验。

结果

共纳入 7397 例患者,其中 43%为正常体重,36%为 I 级-II 级肥胖症,21%为 III 级肥胖症。体重增加与慢性水肿的更晚期阶段相关(ISL 分期 III;最严重的形式);正常体重患者中占 14%,I 级-II 级肥胖症患者中占 18%,III 级肥胖症患者中占 39%(p<0.001)。10 个因素与体重增加独立相关:糖尿病(OR 2.4)、继发性淋巴水肿(OR 2.7)、12 个月内蜂窝织炎/丹毒(OR 1.2)、双侧淋巴水肿(OR 3.6)、压迫治疗(OR 2.1)、肿胀持续时间增加(1-2 年 OR 1.3,2-5 年 OR 2.5,5-10 年 OR 3.6,>10 年 OR 3.5)、活动能力下降(使用辅助工具行走 OR 1.9,坐轮椅 OR 1.2)和年龄(参考<45 岁;45-64 岁 OR 1.5,75-84 岁 OR 0.6,85 岁及以上 OR 0.2)。体重增加与外周动脉疾病(OR 0.7)和慢性水肿控制较差(OR 0.8)的发生率较低相关。肥胖症患者的功能、外观和症状更严重(LYMQOL),生活质量(EuroQol)更低。

结论

肥胖症对慢性水肿有负面影响,导致疾病更晚期。这些患者用压迫疗法控制肿胀更困难。提高对肥胖症作为慢性水肿/淋巴水肿并发症的认识,对于早期发现和制定有效的预防和管理策略非常重要。

相似文献

1
The impact of obesity on chronic oedema/lymphoedema of the leg - an international multicenter cross-sectional study (LIMPRINT).
Int J Obes (Lond). 2024 Sep;48(9):1238-1247. doi: 10.1038/s41366-024-01544-0. Epub 2024 Jul 3.
2
Wounds in chronic leg oedema.
Int Wound J. 2022 Feb;19(2):411-425. doi: 10.1111/iwj.13642. Epub 2021 Jul 13.
4
Cellulitis in chronic oedema of the lower leg: an international cross-sectional study.
Br J Dermatol. 2021 Jul;185(1):110-118. doi: 10.1111/bjd.19803. Epub 2021 May 5.
5
Obesity-related chronic lymphoedema-like swelling and physical function.
QJM. 2015 Mar;108(3):183-7. doi: 10.1093/qjmed/hcu155. Epub 2014 Aug 1.
6
LIMPRINT Study: The Turkish Experience.
Lymphat Res Biol. 2019 Apr;17(2):202-210. doi: 10.1089/lrb.2019.0015.
7
Lymphedema Impact and Prevalence International Study: The Canadian Data.
Lymphat Res Biol. 2019 Apr;17(2):178-186. doi: 10.1089/lrb.2019.0014.
9
LIMPRINT: Estimation of the Prevalence of Lymphoedema/Chronic Oedema in Acute Hospital in In-Patients.
Lymphat Res Biol. 2019 Apr;17(2):135-140. doi: 10.1089/lrb.2019.0024.
10
Audit of skin changes present in referrals to a specialist lymphoedema service.
Br J Community Nurs. 2017 May 1;22 Suppl 5(Sup5):S42-S47. doi: 10.12968/bjcn.2017.22.Sup5.S42.

引用本文的文献

本文引用的文献

1
Body-mass index and risk of obesity-related complex multimorbidity: an observational multicohort study.
Lancet Diabetes Endocrinol. 2022 Apr;10(4):253-263. doi: 10.1016/S2213-8587(22)00033-X. Epub 2022 Mar 4.
3
Adipocytes are larger in lymphedematous extremities than in controls.
J Plast Surg Hand Surg. 2022 Jun;56(3):172-179. doi: 10.1080/2000656X.2021.1953042. Epub 2021 Aug 2.
5
Cellulitis in chronic oedema of the lower leg: an international cross-sectional study.
Br J Dermatol. 2021 Jul;185(1):110-118. doi: 10.1111/bjd.19803. Epub 2021 May 5.
6
Obesity in adults: a clinical practice guideline.
CMAJ. 2020 Aug 4;192(31):E875-E891. doi: 10.1503/cmaj.191707.
7
Body Mass Index and Lymphedema Morbidity: Comparison of Obese versus Normal-Weight Patients.
Plast Reconstr Surg. 2020 Aug;146(2):402-407. doi: 10.1097/PRS.0000000000007021.
8
Effects of weight reduction on the breast cancer-related lymphedema: A systematic review and meta-analysis.
Breast. 2020 Aug;52:116-121. doi: 10.1016/j.breast.2020.05.007. Epub 2020 May 28.
9
Histopathologic Features of Lymphedema: A Molecular Review.
Int J Mol Sci. 2020 Apr 6;21(7):2546. doi: 10.3390/ijms21072546.
10
The clinical characteristics of lower extremity lymphedema in 440 patients.
J Vasc Surg Venous Lymphat Disord. 2020 Sep;8(5):851-859. doi: 10.1016/j.jvsv.2019.11.014. Epub 2020 Jan 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验